We are live on ! Find out more
Royce & Associates

Royce & Associates Portfolio holdings

AUM $12.4B Turnover 20.64%
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+4.19%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$15.3B
AUM Growth
-$295M
Cap. Flow
-$632M
Cap. Flow %
-4.13%
Top 10 Hldgs %
8.02%
Holding
1,164
New
84
Increased
337
Reduced
381
Closed
48
Avg Time Held
2.6 years
Top 10 Avg Time Held
0.7 years
Top 20 Avg Time Held
1.6 years

Top Sells

Rank Stock Value
1
CGNX icon
Cognex
CGNX
+$42.6M
2
MDP
Meredith Corporation
MDP
+$31.4M
3
MKSI icon
MKS Inc
MKSI
+$29.7M
4
THO icon
Thor Industries
THO
+$28.8M
5
CLC
Clarcor
CLC
+$28M

Sector Composition

Rank Sector Weight
1 Industrials 28.98%
2 Technology 17.48%
3 Consumer Discretionary 17.47%
4 Financials 11.77%
5 Materials 7.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TKR icon
951
Timken Company
TKR
$7.75B
$1.25M 0.01%
27,550
– –
2016 Q4
1 quarter
MUX icon
952
McEwen Inc
MUX
$966M
$1.23M 0.01%
40,280
– –
2013 Q2
15 quarters
NGVT icon
953
Ingevity
NGVT
$2.43B
$1.22M 0.01%
+20,000
New +$1.13M
2017 Q1
0 quarters
UFCS icon
954
United Fire Group
UFCS
$1.44B
$1.22M 0.01%
28,417
– –
2013 Q2
15 quarters
BCRX icon
955
BioCryst Pharmaceuticals
BCRX
$2.05B
$1.21M 0.01%
144,000
– –
2016 Q1
4 quarters
TPR icon
956
Tapestry
TPR
$23.6B
$1.2M 0.01%
29,125
-12,275
-30% -$463K
2015 Q4
5 quarters
NLST
957
DELISTED
Netlist, Inc.
NLST
$1.19M 0.01%
1,200,500
+200,500
+20% +$200K
2016 Q3
2 quarters
AMSC icon
958
American Superconductor
AMSC
$1.26B
$1.18M 0.01%
+172,300
New +$1.16M
2017 Q1
0 quarters
IPCC
959
DELISTED
Infinity Property & Casualty C
IPCC
$1.16M 0.01%
12,143
– –
2013 Q2
15 quarters
AAN.A icon
960
DELISTED
The Aaron's Company Inc Class A
AAN.A
$1.16M 0.01%
38,834
– –
2016 Q1
4 quarters
ACGN
961
DELISTED
Aceragen Inc
ACGN
$1.15M 0.01%
+3,419
New +$825K
2017 Q1
0 quarters
STRL icon
962
Sterling Infrastructure
STRL
$13.2B
$1.13M 0.01%
122,300
– –
2013 Q2
15 quarters
CMD
963
DELISTED
Cantel Medical Corporation
CMD
$1.12M 0.01%
+14,000
New +$1.11M
2017 Q1
0 quarters
PSMT icon
964
Pricesmart
PSMT
$5.26B
$1.11M 0.01%
+12,031
New +$1.06M
2017 Q1
0 quarters
CPN
965
DELISTED
Calpine Corporation
CPN
$1.1M 0.01%
100,000
– –
2016 Q4
1 quarter
CERS icon
966
Cerus
CERS
$453M
$1.1M 0.01%
248,000
– –
2013 Q2
15 quarters
PLPM
967
DELISTED
Planet Payment, Inc
PLPM
$1.1M 0.01%
277,000
– –
2016 Q4
1 quarter
CRHM
968
DELISTED
CRH Medical Corporation
CRHM
$1.09M 0.01%
133,000
– –
2016 Q3
2 quarters
GAIA icon
969
Gaia
GAIA
$32.5M
$1.08M 0.01%
108,500
– –
2013 Q2
15 quarters
VRSK icon
970
Verisk Analytics
VRSK
$24.7B
$1.07M 0.01%
13,200
+6,800
+106% +$558K
2013 Q2
15 quarters
LXFR icon
971
Luxfer Holdings
LXFR
$466M
$1.07M 0.01%
87,812
– –
2013 Q2
15 quarters
DCOY icon
972
Decoy Therapeutics
DCOY
$793K
– –
0
– –
2015 Q1
8 quarters
CECO icon
973
Ceco Environmental
CECO
$3.5B
$1.04M 0.01%
99,028
– –
2015 Q3
6 quarters
G icon
974
Genpact
G
$6.25B
$1.04M 0.01%
42,000
+16,000
+62% +$390K
2016 Q4
1 quarter
INVX icon
975
Innovex International
INVX
$1.92B
$1.04M 0.01%
19,000
-34,000
-64% -$2.03M
2016 Q1
4 quarters

Similar funds

Royce & Associates's Q1 2017 Portfolio in Review

As of Q1 2017, Royce & Associates held 1,164 positions worth $15.3B, down 1.9% from $15.6B the previous quarter. Its ten largest holdings account for 8% of the portfolio.

Royce & Associates withdrew a net $632M in Q1 2017, closing 48 positions and reducing 381 holdings. Its most notable exit was Clarcor, an estimated $28M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 29% of assets, down from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in Supreme Industries Inc Class A worth $25.4M.

  • Royce & Associates's largest Q1 2017 buy was Supreme Industries Inc Class A: 1,255,679 shares worth $25.4M.
  • Royce & Associates added most to Fabrinet in Q1 2017, an estimated $32.7M increase.
  • Royce & Associates's biggest Q1 2017 reduction was Cognex, cutting an estimated $42.6M.
  • Royce & Associates fully exited Clarcor in Q1 2017, selling an estimated $28M.
  • Royce & Associates's ten largest holdings make up 8% of its $15.3B portfolio in Q1 2017.
  • Royce & Associates opened 84 new positions and closed 48 in Q1 2017.
  • Royce & Associates's portfolio value fell 1.9% quarter-over-quarter to $15.3B.

Based on Royce & Associates's 13F filing for Q1 2017, filed 11 May 2017.